The aim of this study was to describe the clinical and PSG characteristics of narcolepsy with
cataplexy and their genetic predisposition by using the retrospective patient database of the …

Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors
include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here…

Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or
type-2 (NT2), but only NT1 is accepted as clearly defined entity. Both types of narcolepsies …

Study Objectives: Narcolepsy with cataplexy is tightly associated with the HLA class II allele
DQB1*06:02. Evidence indicates a complex contribution of HLA class II genes to narcolepsy …

Purpose Narcolepsy type-1 (NT1) is a rare chronic neurological sleep disorder with excessive
daytime sleepiness (EDS) as usual first and cataplexy as pathognomonic symptom. …

Narcolepsy with cataplexy is a rare disease with an estimated prevalence of 0.02% in European
populations. Narcolepsy shares many features of rare disorders, in particular the lack of …

Background and Objectives Recent studies fueled doubts as to whether all currently defined
central disorders of hypersomnolence are stable entities, especially narcolepsy type 2 and …

Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by repeated
episodes of REM sleep-related vocalizations and/or complex motor behaviors. Definite …

Increased incidence rates of narcolepsy type-1 (NT1) have been reported worldwide after the
2009–2010 H1N1 influenza pandemic (pH1N1). While some European countries found an …

Little attention has been paid to the long‐term development of idiopathic hypersomnia
symptoms and idiopathic hypersomnia comorbidities. The aim of this study was to describe the …